Dyslipidemia Management

Researchers at Heart Alterations in Cardiac and Systemic Metabolism in Heart Failure Vacuolar H+-ATPase Preserves Cardiolipin Homeostasis Through the Lysosomal-Mitochondrial Axis to Restrain Cardiac Aging Cost of Idling: Skeletal Muscle Myosin ATPase Dysfunction and the Energetic Basis of Exercise Intolerance in HFrEF Bile Acids, Mitochondria, and Myocardial Stiffness: A Shared Mechanism in Fontan Circulation and Metabolic Dysfunction-Associated Steatotic Liver Disease Is Placebo Still Ethical in Trials of Incretin Therapies? Cardiovascular–Kidney–Metabolic Syndrome Stages, Echocardiographic Characteristics, and Heart Failure Risk: The Atherosclerosis Risk in Communities Study Mechanisms of GLP-1 Receptor Agonists in HFpEF: Exploring Weight-Dependent and Independent Drivers of Therapeutic Benefit Lipoprotein(a): An Atherosclerotic Cardiovascular Disease Risk Factor That Can No Longer Be Ignored 2026 Guideline on the Management of Dyslipidemia